These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11012509)

  • 1. A novel method of delivering vasoconstrictors to the nasal passage.
    Davies P; Pandit JJ
    Anaesthesia; 2000 Oct; 55(10):1030. PubMed ID: 11012509
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of intranasal sterile isotonic sea water applications on xylometazoline administration: an experimental study in pigs.
    Nikolaidis E; Eleftheriadou A; Yiotakis I; Lazaris AC; Agrogianis G; Ferekidou E; Keramaris N; Papalois A; Kandiloros D
    Auris Nasus Larynx; 2010 Feb; 37(1):71-6. PubMed ID: 19414231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of the use of xylometazoline nasal spray in young children undergoing lacrimal surgery: an observational study.
    Joganathan V; Beigi B
    Eur J Ophthalmol; 2018 May; 28(3):279-281. PubMed ID: 29077183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Intranasal Vasoconstrictors on Blood Pressure: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Bellew SD; Johnson KL; Nichols MD; Kummer T
    J Emerg Med; 2018 Oct; 55(4):455-464. PubMed ID: 30195946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal Medication Administration Using a Squeeze Bottle Atomizer Results in Overdosing if Deployed in Supine Patients.
    Goldhammer JE; Dobish MA; McAnulty JT; Smaka TJ; Epstein RH
    Anesth Analg; 2017 Aug; 125(2):453-457. PubMed ID: 27828797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xylometazoline pretreatment reduces nasotracheal intubation-related epistaxis in paediatric dental surgery.
    El-Seify ZA; Khattab AM; Shaaban AA; Metwalli OS; Hassan HE; Ajjoub LF
    Br J Anaesth; 2010 Oct; 105(4):501-5. PubMed ID: 20682569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal preparation.
    Phillips J; McRae D
    Clin Otolaryngol; 2005 Dec; 30(6):566-7. PubMed ID: 16402988
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system.
    Dhuria SV; Hanson LR; Frey WH
    J Pharmacol Exp Ther; 2009 Jan; 328(1):312-20. PubMed ID: 18945930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Nasal and instrument preparation prior to rigid and flexible nasendoscopy: a systematic review.
    De Freitas RP; Hannah BC
    J Laryngol Otol; 2009 Oct; 123(10):1188; author reply 1188-9. PubMed ID: 19457273
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vasoactive therapy of the mucosa of the nasopharynx and oropharynx in dental surgery].
    Bilder J
    Cesk Stomatol; 1976 Jul; 76(4):289-92. PubMed ID: 1067917
    [No Abstract]   [Full Text] [Related]  

  • 11. Onzetra Xsail--sumatriptan nasal powder.
    Med Lett Drugs Ther; 2016 Jul; 58(1499):92-3. PubMed ID: 27403783
    [No Abstract]   [Full Text] [Related]  

  • 12. Vasoconstrictive decongestants: the authorities' dithering leaves patients in danger.
    Prescrire Int; 2013 Mar; 22(136):72. PubMed ID: 23593693
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug-clinics. The drug of the month. Imitrex nasal spray (sumatriptan)].
    Scheen AJ
    Rev Med Liege; 1997 Sep; 52(9):610-2. PubMed ID: 9441347
    [No Abstract]   [Full Text] [Related]  

  • 14. Nasal delivery of antimigraine drugs: clinical rationale and evidence base.
    Rapoport A; Winner P
    Headache; 2006 Nov; 46 Suppl 4():S192-201. PubMed ID: 17078851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sumatriptan nasal spray for the treatment of cluster headache].
    Watanabe M; Oda A
    No To Shinkei; 2005 Jan; 57(1):65-8. PubMed ID: 15782603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of some vasoconstrictors on the nasal volume in pathologic conditions in man; a physiologic study.
    RICHTNER NG
    Acta Otolaryngol; 1950 Dec; 38(6):528-37. PubMed ID: 14856683
    [No Abstract]   [Full Text] [Related]  

  • 19. A new vasoconstrictor, a preliminary report.
    STEINBERG H
    Calif Med; 1953 Jun; 78(6):507. PubMed ID: 13059628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxymetazoline in the treatment of allergic and non-infectious conjunctivitis.
    Fox SL; Samson CR; Danzig MR
    J Int Med Res; 1979; 7(6):528-30. PubMed ID: 391626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.